Found: 11
Select item for more details and to access through your institution.
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1568, doi. 10.1007/s10637-021-01120-7
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 5, p. 756, doi. 10.1080/14397595.2018.1553489
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 4, p. 514, doi. 10.3109/14397595.2014.995875
- By:
- Publication type:
- Article
Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study.
- Published in:
- Rheumatology, 2019, v. 58, n. 1, p. 70, doi. 10.1093/rheumatology/key250
- By:
- Publication type:
- Article
Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 11, doi. 10.1002/cpdd.741
- By:
- Publication type:
- Article
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.
- Published in:
- Breast Cancer (13406868), 2022, v. 29, n. 6, p. 1088, doi. 10.1007/s12282-022-01390-w
- By:
- Publication type:
- Article
Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 10, p. 1884, doi. 10.1111/jgh.15923
- By:
- Publication type:
- Article
Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-0932-2
- By:
- Publication type:
- Article
Evaluation of Data for Multi-Regional Trials: A Three-Layer Approach.
- Published in:
- Applied Clinical Trials, 2013, v. 22, n. 11, p. 25
- By:
- Publication type:
- Article
Oral tofacitinib efficacy, safety and tolerability in Japanese patients with moderate to severe plaque psoriasis and psoriatic arthritis: A randomized, double-blind, phase 3 study.
- Published in:
- Journal of Dermatology, 2016, v. 43, n. 8, p. 869, doi. 10.1111/1346-8138.13258
- By:
- Publication type:
- Article